➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Dow
McKesson
Merck
Colorcon

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Litigation Details for Nuvasive, Inc. v. Alphatec Holdings, Inc. (S.D. Cal. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Nuvasive, Inc. v. Alphatec Holdings, Inc. (S.D. Cal. 2018)

Small Molecule Drugs cited in Nuvasive, Inc. v. Alphatec Holdings, Inc.

Details for Nuvasive, Inc. v. Alphatec Holdings, Inc. (S.D. Cal. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-04-10 281 Order on Motion for Summary Judgment 9,833,227; U.S. Patent No. 8,753,270; U.S. Patent No. 9,924,859; and U.S. Patent No. 9,974,531. 28…of the ‘832 patent, claims 21, 22, 24 and 16 27 of the ‘780 patent, and claims 1, 2, 3, 6 and 12 of the…device. Id. at 1362. 6 A. The ‘832 Patent 7 The ‘832 patent is for a “Surgical… is GRANTED IN PART and DENIED 6 IN PART. 7 The patents-at-issue generally claim a surgical…patient. [Doc. No. 1-12 at Col. 3:1-6.] The claims of the ‘270 patent External link to document
2020-04-24 282 Order on Motion for Summary Judgment ‘227, ‘270 and ‘531 patents, and Brian Snider, an inventor of the ‘859 patent, 10 and therefore should… No. 1-12]; U.S. Patent No. 9,924,859 [Doc. No. 110-44]; and U.S. Patent No. 9,974,531 [Doc. No. 110- …of the surgical access system claimed in the ‘859 patent 5 includes the limitation of 6 a …summary judgment of non- 3 infringement of the ‘859 patent for failure to meet this claim limitation is …,832 [Doc. No. 1-8]; U.S. Patent No. 9,833,227 [Doc. No. 1-10]; U.S. Patent No. 8,753,270 [Doc. No External link to document
2020-04-30 284 Order on Motion to Exclude 17 Warsaw Orthopedics, Inc. v. NuVasive, Inc., 778 F.3d 1365, 1375 (Fed. Cir. 2015). 18 Alphatec contends… Alphatec's Motion to Exclude Experts [Doc. No. 251 ]. Signed by Judge Cathy Ann Bencivengo on 4/30/2020… Defendants. [Doc. No. 251] 15 16 17 Before the Court is Alphatec’s … testimony of NuVasive’s 18 experts. [Doc. No. 251.] NuVasive filed an opposition. [Doc. No. 259.] Alphatec…the nonobviousness the patents-at-issue. Dr. Youssef opines that the 4 patented inventions are embodied External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Baxter
Moodys
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.